We are live on ! Find out more
CIM

Contravisory Investment Management Portfolio holdings

AUM $566M
1-Year Est. Return 42.93%
This Fund
S&P 500
This Quarter Est. Return
+14.73%
1 Year Est. Return
+42.93%
3 Year Est. Return
+129.34%
5 Year Est. Return
+198.47%
10 Year Est. Return
+603.03%
AUM
$258M
AUM Growth
+$26.3M
Cap. Flow
-$3.22M
Cap. Flow %
-1.25%
Top 10 Hldgs %
26.69%
Holding
359
New
67
Increased
44
Reduced
137
Closed
56

Top Buys

Rank Stock Value
1
NEE icon
NextEra Energy
NEE
+$4.09M
2
CMCSA icon
Comcast
CMCSA
+$4.04M
3
TMUS icon
T-Mobile US
TMUS
+$3.96M
4
SPG icon
Simon Property Group
SPG
+$3.93M
5
DIS icon
Walt Disney
DIS
+$3.89M

Top Sells

Rank Stock Value
1
LH icon
Labcorp
LH
+$4.44M
2
VFC icon
VF Corp
VFC
+$4.33M
3
FTV icon
Fortive
FTV
+$3.33M
4
TIF
Tiffany & Co.
TIF
+$3.23M
5
CIT
CIT Group Inc.
CIT
+$3.15M

Sector Composition

Rank Sector Weight
1 Technology 25.39%
2 Healthcare 16%
3 Financials 9.85%
4 Consumer Staples 8.74%
5 Real Estate 8.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NSC icon
201
Norfolk Southern
NSC
$75.1B
$57K 0.02%
304
– –
BA icon
202
Boeing
BA
$185B
$56K 0.02%
148
+8
+6% +$3.08K
CNI icon
203
Canadian National Railway
CNI
$76.6B
$55K 0.02%
613
– –
GLD icon
204
SPDR Gold Trust
GLD
$141B
$55K 0.02%
450
– –
INFO
205
DELISTED
IHS Markit Ltd. Common Shares
INFO
$55K 0.02%
+1,013
New +$53K
AXP icon
206
American Express
AXP
$230B
$54K 0.02%
492
+46
+10% +$4.83K
COP icon
207
ConocoPhillips
COP
$141B
$54K 0.02%
816
+55
+7% +$3.7K
CSX icon
208
CSX Corp
CSX
$93.1B
$54K 0.02%
2,154
+210
+11% +$4.86K
GSK icon
209
GSK
GSK
$106B
$54K 0.02%
1,029
– –
PFE icon
210
Pfizer
PFE
$153B
$54K 0.02%
1,333
+118
+10% +$4.73K
USB icon
211
US Bancorp
USB
$99.6B
$54K 0.02%
1,118
– –
ICE icon
212
Intercontinental Exchange
ICE
$84.4B
$53K 0.02%
694
+65
+10% +$4.87K
ABBV icon
213
AbbVie
ABBV
$435B
$52K 0.02%
650
– –
ERIC icon
214
Ericsson
ERIC
$33.3B
$52K 0.02%
+5,689
New +$51.4K
SPGI icon
215
S&P Global
SPGI
$120B
$52K 0.02%
246
+177
+257% +$34.3K
AZN icon
216
AstraZeneca
AZN
$250B
$51K 0.02%
+637
New +$50.2K
ECL icon
217
Ecolab
ECL
$79.9B
$51K 0.02%
288
– –
XOM icon
218
ExxonMobil
XOM
$634B
$51K 0.02%
631
+6
+1% +$457
LAD icon
219
Lithia Motors
LAD
$8.26B
$50K 0.02%
540
– –
UNH icon
220
UnitedHealth
UNH
$370B
$50K 0.02%
204
+19
+10% +$4.84K
BT
221
DELISTED
BT Group plc (ADR)
BT
$50K 0.02%
+3,408
New +$51K
ADBE icon
222
Adobe
ADBE
$105B
$49K 0.02%
185
-20
-10% -$5.04K
AMGN icon
223
Amgen
AMGN
$222B
$49K 0.02%
259
– –
MDT icon
224
Medtronic
MDT
$112B
$49K 0.02%
536
+56
+12% +$5.01K
SONY icon
225
Sony
SONY
$138B
$49K 0.02%
5,850
– –
7 8
9
10 11

Similar funds

SAM
Satovsky Asset Management New York $566M AUM 15.8% 1-Year Est. Return
PAM
Peak Asset Management Louisville, Colorado $567M AUM 16.44% 1-Year Est. Return
PEP
Providence Equity Partners Providence, Rhode Island $565M AUM 37.52% 1-Year Est. Return
LC
Lavaca Capital Houston, Texas $564M AUM 4.6% 1-Year Est. Return
BRIM
Broad Run Investment Management Arlington, Virginia $568M AUM 50.18% 1-Year Est. Return
KBG
Kahn Brothers Group New York $564M AUM 25.3% 1-Year Est. Return
AHSW
Adventist Health System West Roseville, California $564M AUM 17.1% 1-Year Est. Return
PSC
Patient Square Capital Menlo Park, California $564M AUM 261.3% 1-Year Est. Return

Contravisory Investment Management's Q1 2019 Portfolio in Review

As of Q1 2019, Contravisory Investment Management held 359 positions worth $258M, up 11% from $232M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Contravisory Investment Management's Q1 2019 filing shows 67 new, 44 increased, 137 reduced and 56 closed positions. Its largest new stake was T-Mobile US: 56,597 shares worth $3.91M. The largest sale was Labcorp, an estimated $4.44M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 25% a quarter earlier, followed by Healthcare and Financials.

  • Contravisory Investment Management's largest Q1 2019 buy was T-Mobile US: 56,597 shares worth $3.91M.
  • Contravisory Investment Management added most to NextEra Energy in Q1 2019, an estimated $4.09M increase.
  • Contravisory Investment Management's biggest Q1 2019 reduction was Schwab US Large- Cap ETF, cutting an estimated $1.19M.
  • Contravisory Investment Management fully exited Labcorp in Q1 2019, selling an estimated $4.44M.
  • Contravisory Investment Management's ten largest holdings make up 27% of its $258M portfolio in Q1 2019.
  • Contravisory Investment Management opened 67 new positions and closed 56 in Q1 2019.
  • Contravisory Investment Management's portfolio value rose 11% quarter-over-quarter to $258M.

Based on Contravisory Investment Management's 13F filing for Q1 2019, filed 8 Apr 2019.